Abstract: In one example a system is for post-processing a three-dimensional (3D) object generated in an additive manufacturing process in which an identifiable agent is applied to a portion of a build material to form a portion of the 3D object. The system comprises an identification unit and a sensor. The identification unit is to cause the identifiable agent to become distinguishable to thereby cause the portion of the 3D object, corresponding to the portion of build material to which the identifiable agent was applied, to be distinguishable from any build material remnant disposed on the 3D object and to which no identifiable agent was applied. The sensor is to distinguish the build material remnant from the portion of the 3D object.

Abstract: In one example a system is for post-processing a three-dimensional (3D) object generated in an additive manufacturing process in which an identifiable agent is applied to a portion of a build material to form a portion of the 3D object. The system comprises an identification unit and a sensor. The identification unit is to cause the identifiable agent to become distinguishable to thereby cause the portion of the 3D object, corresponding to the portion of build material to which the identifiable agent was applied, to be distinguishable from any build material remnant disposed on the 3D object and to which no identifiable agent was applied. The sensor is to distinguish the build material remnant from the portion of the 3D object.

Abstract: Disclosed herein are kits, methods, systems, and compositions for threedimensional printing. In an example, disclosed herein is a multi-fluid kit for threedimensional printing comprising: a marking agent comprising a marking component which is a fluorescent color agent that is activated by ultraviolet radiation to emit light in the visible range of from about 400 nm to about 780 nm; a first fusing agent; a second fusing agent different from the first fusing agent; and a detailing agent.

Abstract: The present disclosure relates to light guide plates and methods for three-dimensional printing of light guide plates. In some examples, the method for 3D printing a light guide plate comprises: forming a plate body by depositing a layer of transparent build material on a build platform; based on a 3D object model of the plate body, inkjet printing fusing agent onto at least a portion of the layer of the transparent build material; and irradiating the fusing agent to heat the transparent build material and at least partially bind the portion of the transparent build material.

Abstract: A pulmonary delivery medicament comprises a plurality of particulates, the particulates comprising a structural matrix and a water insoluble and/or crystalline active agent. The particulates have a geometric diameter of 0.5 to 50 ?m. The water insoluble active agent can be a fungicide, antibiotic, budesonide. A method of making the medicament comprises forming a liquid feedstock, and forming a feedstock suspension by suspending in the liquid feedstock, the active agent and an excipient capable of forming a structural matrix, such as a phospholipid. The feedstock suspension is spray dried to produce the particulates.

Abstract: The present disclosure is drawn to an electrostatic ink composition comprising: (a) a carrier liquid; (b) particles comprising: (i) a polymer having a melt flow rate of less than 60 g/10 minutes, (ii) a colorant, (c) a charge director, wherein the electrostatic ink composition excludes a positively charged organic molecule or an organic molecule capable of becoming a positively charged organic molecule during an electrostatic printing process. Also disclosed herein is a method of producing a electrostatic ink composition and a method of electrophotographic printing an electrostatic ink composition.

Abstract: A respiratory dispersion for pulmonary delivery comprises one or more bioactive agents, a suspension medium, and a plurality of perforated microstructures having a mean aerodynamic diameter of less than 5 ?m. The suspension medium comprises at least one propellant and permeates the perforated microstructures.

Abstract: Engineered particles are provided may be used for the delivery of a bioactive agent to the respiratory tract of a patient. The particles may be used in the form of dry powders or in the form of stabilized dispersions comprising a nonaqueous continuous phase. In particularly preferred embodiments the particles may be used in conjunction with an inhalation device such as a dry powder inhaler, metered dose inhaler or a nebulizer.

Abstract: Stabilized dispersions are provided for the delivery of a bioactive agent. The dispersions preferably comprise a plurality of perforated microstructures dispersed in a suspension medium that typically comprises a liquid fluorochemical. As density variations between the suspended particles and suspension medium are minimized and attractive forces between microstructures are attenuated, the disclosed dispersions are particularly resistant to degradation, such as by settling or flocculation. In particularly preferred embodiments the stabilized dispersions may be directly administered to the lung of a patient using an endotracheal tube or bronchoscope.

Abstract: A respiratory dispersion for pulmonary delivery comprises one or more bioactive agents, a suspension medium, and a plurality of perforated microstructures having a mean aerodynamic diameter of less than 5 ?m. The suspension medium comprises at least one propellant and permeates the perforated microstructures.

Abstract: A pulmonary delivery medicament comprises a plurality of particulates, the particulates comprising a structural matrix and a water insoluble and/or crystalline active agent. The particulates have a geometric diameter of 0.5 to 50 ?m. The water insoluble active agent can be a fungicide, antibiotic, budesonide. A method of making the medicament comprises forming a liquid feedstock, and forming a feedstock suspension by suspending in the liquid feedstock, the active agent and an excipient capable of forming a structural matrix, such as a phospholipid. The feedstock suspension is spray dried to produce the particulates.

Abstract: A respiratory dispersion is provided for the pulmonary delivery of at least two bioactive agents. The dispersion comprises a propellant suspension medium having dispersed therein a plurality of perforated microstructures, wherein the two bioactive agents are incorporated into individual perforated microstructures.

Abstract: Stabilized dispersions are provided for the delivery of a bioactive agent to the respiratory tract of a patient. The dispersions preferably comprise a plurality of perforated microstructures dispersed in a suspension medium that typically comprises a hydrofluoroalkane propellant. As density variations between the suspended particles and suspension medium are minimized and attractive forces between microstructures are attenuated, the disclosed dispersions are particularly resistant to degradation, such as, by settling or flocculation. In particularly preferred embodiments, the stabilized dispersions may be administered to the lung of a patient using a metered dose inhaler.

Abstract: Stabilized dispersions are provided for the delivery of a bioactive agent. The dispersions preferably comprise a plurality of perforated microstructures dispersed in a suspension medium that typically comprises a liquid fluorochemical. As density variations between the suspended particles and suspension medium are minimized and attractive forces between microstructures are attenuated, the disclosed dispersions are particularly resistant to degradation, such as by settling or flocculation. In particularly preferred embodiments the stabilized dispersions may be directly administered to the lung of a patient using an endotracheal tube or bronchoscope.

Abstract: A respiratory dispersion is provided for the pulmonary delivery of at least two bioactive agents. The dispersion comprises a propellant suspension medium having dispersed therein a plurality of perforated microstructures, wherein the two bioactive agents are incorporated into individual perforated microstructures.

Abstract: Stabilized dispersions are provided for the delivery of a bioactive agent. The dispersions preferably comprise a plurality of perforated microstructures dispersed in a suspension medium that typically comprises a liquid fluorochemical. As density variations between the suspended particles and suspension medium are minimized and attractive forces between microstructures are attenuated, the disclosed dispersions are particularly resistant to degradation, such as by settling or flocculation. In particularly preferred embodiments the stabilized dispersions may be directly administered to the lung of a patient using an endotracheal tube or bronchoscope.

Abstract: Engineered particles are provided may be used for the delivery of a bioactive agent to the respiratory tract of a patient. The particles may be used in the form of dry powders or in the form of stabilized dispersions comprising a nonaqueous continuous phase. In particularly preferred embodiments the particles may be used in conjunction with an inhalation device such as a dry powder inhaler, metered dose inhaler or a nebulizer.

Abstract: Methods for digitally printing on various articles, particularly ceramic articles, are disclosed. A first step includes applying a fluid glazing material to an article creating a coated surface. The fluid glazing material can either contain an underprinting agent for accepting and adhering chromophores to the fluid glazing material, or the underprinting agent can be jetted onto the fluid glazing material prior to the jetting of chromophores onto the article. A chromophore-containing fluid is then jetted onto the ceramic article and the article is fired. Additionally, an inkjettable composition is disclosed having a large amount of metal ion present in the composition.

Abstract: Stabilized dispersions are provided for the delivery of a bioactive agent. The dispersions preferably comprise a plurality of perforated microstructures dispersed in a suspension medium that typically comprises a liquid fluorochemical. As density variations between the suspended particles and suspension medium are minimized and attractive forces between microstructures are attenuated, the disclosed dispersions are particularly resistant to degradation, such as by settling or flocculation. In particularly preferred embodiments the stabilized dispersions may be directly administered to the lung of a patient using an endotracheal tube or bronchoscope.

Abstract: The described embodiments relate to slotted substrates. One exemplary method forms a feature into a substrate, at least in part, by directing a laser beam at the substrate. During at least a portion of said directing, the method supplies a conductive material proximate the substrate.